[ad_1]
Resources:
Linda Geng, MD, PhD, assistant professor of medication, Stanford University co-director, Article-Acute COVID-19 Syndrome Centre.
Diana Güthe, founder, COVID aid team Survivor Corps.
Michael Peluso, MD, infectious ailments medical doctor, assistant professor of medicine, College of California, San Francisco.
Zachary Schwartz, MD, clinical director, Write-up-COVID-19 Restoration Clinic, Vancouver Common Clinic, Canada.
Alexander Truong, MD, pulmonologist, Emory University University of Drugs.
Monica Verduzco-Gutierrez, MD, actual physical drugs and rehabilitation health care provider director, submit-COVID recovery plan and clinic, San Antonio, TX.
Character: “Promotion of non-evidence-primarily based therapeutics within individual-led Long COVID assist groups.”
Facebook: @COVID19survivorcorps, May possibly 27, 2022.
Hormone and Metabolic Investigate: “Post COVID and Apheresis – Where by are we Standing?”
The BMJ: “Long covid and apheresis: a wonder overcome marketed on a hypothesis of hope,” “Long covid people journey abroad for costly and experimental ‘blood washing.'”
Fda: “FDA Warns About Stem Cell Therapies,” “Dietary Supplements.”
Stem Cell Studies: “Ethical troubles and general public interaction in the growth of mobile-based treatments for COVID-19: Classes from the pandemic.”
Mobile Stem Cell: “The American stem mobile offer in 2021: U.S. firms promoting unlicensed and unproven stem cell interventions.”
Scientific Reviews: “Hyperbaric oxygen therapy increases neurocognitive functions and indications of write-up-COVID situation: randomized controlled trial.
[ad_2]
Supply url
